The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi ...

Enoxaparin Sodium (Preservative Free) Prefilled Syringes had US brand and generic sales of approximately $530 million, according to IQVIA Health over a 12-month period ending March 2023. Techdow USA’s ...

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A ...

Reference Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. [press release].

Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.

The French company agreed to buy 150 million syringes a year, and Unilife expects to get between $5 million and $15 million in milestone payments out of the deal, which can be extended through 2024.

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

Enoxaparin Sodium (Preservative Free) Prefilled Syringes had US brand and generic sales of approximately $530 million, according to IQVIA Health over a 12-month period ending March 2023.

Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox.